BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lotivibart readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Lotivibart\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07053384-974@assetmemo.bio
DTSTAMP:20261121T004959Z
DTSTART;VALUE=DATE:20270122
DTEND;VALUE=DATE:20270123
SUMMARY:Lotivibart: Phase 1 readout est. (NCT07053384)
DESCRIPTION:Lotivibart\, phase 1\, HIV.\nStudy: A Study to Investigate the 
 Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and 
 Activity of the Viral Reservoir in People Living With HIV\nEstimated prima
 ry completion: 22 January 2027. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/lotivibart#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT07053384
URL:https://assetmemo.bio/drug/lotivibart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
